Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition

• Ziyu Wu,

  Roles Methodology, Writing – original draft

  Affiliations NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China, Department of Geriatric Medicine, Fujian Provincial Hospital, Fujian Provincial Center for Geriatrics, Fujian Provincial Key Laboratory of Geriatric Disease, The Provincial Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China

  ⨯
• Dan Li,

  Roles Data curation

  Affiliation NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

  ⨯
• Dingyuan Tian,

  Roles Data curation

  Affiliation NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

  ⨯
• Xuejun Liu ,

  Roles Supervision

  * E-mail: xuejunliu2020@163.com (XL); wuzhongming@tmu.edu.cn (ZW)

  Affiliation NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

  ⨯
• Zhongming Wu

  Roles Funding acquisition, Writing – review & editing

  * E-mail: xuejunliu2020@163.com (XL); wuzhongming@tmu.edu.cn (ZW)

  Affiliations NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China, Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

  https://orcid.org/0000-0003-4133-9759

  ⨯